Profile change history

What changed for Eloralintide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Eloralintide identity.

20Total events
20Record additions
0Version changes
2Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 20 connected records →

Showing the latest 20 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT06230523

PeptideScanner retained ClinicalTrials.gov record NCT06230523 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-06-24, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
June 24, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06916065

PeptideScanner retained ClinicalTrials.gov record NCT06916065 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
January 30, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06916091

PeptideScanner retained ClinicalTrials.gov record NCT06916091 at 2026-11-16T01:48:01.052Z. Its registry update date was 2025-11-19, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
November 19, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07215559

PeptideScanner retained ClinicalTrials.gov record NCT07215559 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-09, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
October 9, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07282600

PeptideScanner retained ClinicalTrials.gov record NCT07282600 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
November 4, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07321886

PeptideScanner retained ClinicalTrials.gov record NCT07321886 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-09-22, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
September 22, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07353931

PeptideScanner retained ClinicalTrials.gov record NCT07353931 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
November 4, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07369011

PeptideScanner retained ClinicalTrials.gov record NCT07369011 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
November 4, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07392190

PeptideScanner retained ClinicalTrials.gov record NCT07392190 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
November 4, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07401862

PeptideScanner retained ClinicalTrials.gov record NCT07401862 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
June 4, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07426380

PeptideScanner retained ClinicalTrials.gov record NCT07426380 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-19, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
August 19, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07589608

PeptideScanner retained ClinicalTrials.gov record NCT07589608 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
October 8, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07665879

PeptideScanner retained ClinicalTrials.gov record NCT07665879 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
July 16, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07701083

PeptideScanner retained ClinicalTrials.gov record NCT07701083 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
September 29, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07738614

PeptideScanner retained ClinicalTrials.gov record NCT07738614 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-20, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
August 20, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07765511

PeptideScanner retained ClinicalTrials.gov record NCT07765511 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-14, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
August 14, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07808060

PeptideScanner retained ClinicalTrials.gov record NCT07808060 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
October 8, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07900633

PeptideScanner retained ClinicalTrials.gov record NCT07900633 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-03, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
November 3, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07935304

PeptideScanner retained ClinicalTrials.gov record NCT07935304 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
November 13, 2026
Evidence lane
Clinical trials
Record added

Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.

PubMed lists PMID 41559929 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase I, Multicenter Study, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug eloralintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 15, 2026
Evidence lane
Literature metadata